Identification of women with early breast cancer by analysis of p43-positive lymphocytes

British Journal of Cancer

Volumn 80, Issue 5-6, 1999, Pages 874-878

  Auerbach, L ^a   Hellan, M ^a   Stierer, M ^b   Rosen, A C ^c   Ausch, C ^c   Obwegeser, R ^a   Kubista, E ^a   Wolf, G ^a   Rosen, H R ^c   Panzer, S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b HANUSCH HOSPITAL   (Austria)

^c DANUBE HOSPITAL   (Austria)

Author keywords

Breast cancer; Flow cytometry; Lymphocytes; p43; T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; ISOFERRITIN; MONOCLONAL ANTIBODY; TUMOR MARKER;

ARTICLE; BENIGN TUMOR; BREAST BIOPSY; BREAST CANCER; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, NEOPLASM; BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LYMPHOCYTE SUBSETS; PEPTIDE ELONGATION FACTOR TU; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0032948452     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690434     Document Type: Article

References (32)

1. Arnesson L, Vitak B, Manson J, Fagerberg G and Smeds S (1995) Diagnostic outcome of repeated mammography screening. World J Surg 19: 372-377
2. Bach F, Geller R, Nelson P, Panzer S, Gromo G, Benfield M, Inverardi L, Podack E, Witson J and Houchins J (1989) A 'minimal signal-stepwise activation' analysis of functional maturation of T lymphocytes. Immunol Rev 111: 35-57
3. Bilik R, Mor C, Hazaz B and Moroz C (1989) Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer. Cancer Immunol Immunother 28: 143-147
4. Black W, Nease R and Tosteson A (1995) Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 87: 720-731
5. Bloom H and Richardson W (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11: 259-364
6. Ciatto S, Rosselli-Del T and Zappa M (1995) The detectability of breast cancer by screening mammography. Br J Cancer 71: 337-339
7. Fargion S, Fracanzani A, Bando B, Arosio P, Levi S and Fiorelli G (1991) Specific binding sites of H-ferritin on human lymphocytes modulation during cellular proliferation and potential implication in cell growth control. Blood 78: 1056-1061
8. Flanagan F, Dehdashti F and Siegel B (1998) PET in breast cancer. Semin Nucl Med 28: 290-302
9. Friedrich M (1998) MRI of the breast: state of the art. Eur Radiol 8: 707-725
10. Garty B, Kaminsky E and Moroz C (1995) The immunosuppressive human placental ferritin subunit p43 is produced by activated CD4+ lymphocytes. Clin Diagn Lab Immunol 2: 225-226
11. Harris R and Leininger L (1995) Clinical strategies for breast cancer screening: weighing and using the evidence. Ann Intern Med 122: 539-547
12. Hiatt R and Pasick R (1996) Unsolved problems in early breast cancer detection: focus on the undeserved. Breast Cancer Res Treat 40: 37-51
13. Leitch A (1995) Controversies in breast cancer screening. Cancer 76: 2064-2069
14. Lidbrink E, Elfving J, Frisell J and Jonsson E (1996) Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial. Br Med J 312: 273-276
15. Maes R, Dronkers D, Hendriks J, Thijssen M and Nab H (1997) Do non-specific minimal signs in a biennial mammographic breast cancer screening programme need further diagnostic assessment? Br J Radiol 70: 34-38
16. Maymon R and Moroz C (1996) Placental isoferritin: a new biomarker from conception to delivery. Br J Obstet Gynaecol 103: 301-305
17. Meuer S, Cooper D, Hodgdon J, Hussey R, Fitgerald K, Schlossman S and Reinherz E (1983) Identification of the receptor for antigen and major histocompatibility complex on human inducer T lymphocytes. Science 222: 1239-1242
18. Moroz C, Giler S, Kupfer B and Urca I (1977) Lymphocytes bearing surface ferritin in patients with Hodgkin's disease and breast cancer. N Engl J Med 298: 1175-1176
19. Moroz C, Kupfer B, Twig S and Parhami S (1985) Preperation and characterization of monoclonal antibodies specific to placenta ferritin. Clin Chim Acta 148: 111-118
20. Moroz C, Kahn M, Ron E, Luria H and Chaimoff C (1989a) The use of oncofetal ferritin-hearing lymphocytes as a marker for the screening, diagnosis, and follow-up of patients with early breast malignancy screening of 3400 women. Cancer 64: 691-697
21. Moroz C, Misrock S and Siegal F (1989b) Isoferritins in HIV infection: relation to clinical stage and the pathogenesis of AIDS, AIDS 3: 11-16
22. Moroz C, Chetrit A, Kahn M and Modan B (1997) FBL blood test as a predictive marker of breast cancer in high risk women. Med Oncol 14: 39-42
23. Panzer S, Madden M and Matsushi M (1993) Interaction of IL-1, IL-6 and tumour necrosis factor-alpha (TNF-α) in human T cells activated by murine antigen. Clin Exp Immunol 93: 471-478
24. Reinerova M, Rosen H, Veselovska Z, Stierer M and Svec J (1993) Expression of p43 associated placental isoferritin (PLF) correlates inversely with cell growth in breast cancer cell lines MCF-7 and T47-D. Neosplasma 40: 147-151
25. Rosen H, Moroz C, Reiner A, Reinerova M, Stierer M, Svec J, Schemper M and Jakesz R (1992) Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancer. Breast Cancer Res Treat 24: 17-26
26. Rosen H, Stierer M, Gottlicher J, Wolf H, Spoula H and Eibl M (1993) Determination of placental ferritin-positive peripheral lymphocytes in early stages of breast cancer. Am J Surg 165: 213-217
27. Rosen H, Ausch C, Reiner G, Reinerova M, Svec J, Tuchler H, Schiessel R and Moroz C (1996) Immunosuppression by breast cancer associated p43 - effect of immunomodulators. Breast Cancer Res Treat 41: 171-176
28. Sedlak J, Reinerova M, Hunakova L, Ausch C, Chorvath B, Rosen H and Moroz C (1995) Alterations of cell surface antigens induced by placental isoform of ferritin in human carcinoma cell lines. Cancer Lett 94: 101-106
29. Sickles E (1994) Non palpable, circumscribed, non-calcified solid breast masses: likelihood of malignancy based on lesion size and age of patient. Radiology 192: 439-143
30. Sirota L, Kupfer B and Moroz C (1989) Placental isoferritin as a physiological downregulator of cellular immunoreactivity during pregnancy. Clin Exp Immunol 77: 257-262
31. Stierer M, Rosen H, Weber R, Hanak H, Auerbach L, Spona J and Tochler H (1995) A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictor of early recurrence in primary breast cancer. Breast Cancer Res Treat 36: 11-21
32. Tabar L, Fagerberg G, Chen H, Duffy S, Smart C, Gad A and Smith R (1995) Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer 75: 2507-2517